MediBeacon (St. Louis) recently announced that it has won FDA breakthrough device designation for its Transdermal GFR Measurement System (TGFR). TGFR is one of several products granted breakthrough status, FDA’s expedited path outlined in the 21st Century Cures Act. The product measures glomerular filtration rates (GFRs) in patients with impaired or normal renal function. TGFR is considered […]
MediBeacon Inc
Fujifilm Medical Systems names new COO, CMO | Personnel Moves
Fujifilm Holdings (TSE:4901) said its Fujifilm Medical Systems U.S.A. subsidiary lured an Accuray (NSDQ:ARAY) executive and a physician from the University of Southern California to its executive roster effective Sept. 28. The Stamford, Conn.-based company said Johann Fernando, formerly Accuray’s vice president & general manager, was named to be its operations chief. Dr. Diku Mandavia, who has […]
MediBeacon signals $22.5m for non-invasive kidney monitor
Non-invasive kidney function monitor developer MediBeacon said it acquired $22.4 million in investment financing through an agreement with HC2 Holdings subsidiary Pansend LLC. The MediBeacon system uses an optical skin sensor and proprietary opti-reactive glowing agent to provide real time monitoring of kidney function, St. Louis, Mo.-based MediBeacon said. “Without financial backing, some of the […]